Cited by 60Amyotrophic Lateral Sclerosis ResearchNeurogenetic and Muscular Disorders ResearchAmyloidosis: Diagnosis, Treatment, Outcomes

Factors predicting one-year mortality in amyotrophic lateral sclerosis patients - data from a population-based registry

Open access
Wolf, Joachim, Safer, Anton, Wöhrle, Johannes C, Palm, Frederick, Nix, Wilfred A, Maschke, Matthias, Grau, Armin J·2014·BMC Neurology

Abstract

BACKGROUND: Survival in amyotrophic lateral sclerosis varies considerably. About one third of the patients die within 12 months after first diagnosis. The early recognition of fast progression is essential for patients and neurologists to weigh up invasive therapeutic interventions. In a prospective, population-based cohort of ALS patients in Rhineland-Palatinate, Germany, we identified significant prognostic factors at time of diagnosis that allow prediction of early death within first 12 months. METHODS: Incident cases, diagnosed between October 2009 and September 2012 were enrolled and followed up at regular intervals of 3 to 6 months. Univariate analysis utilized the Log-Rank Test to identify association between candidate demographic and disease variables and one-year mortality. In a second step we investigated a multiple logistic regression model for the optimal prediction of one-year mortality rate. RESULTS: In the cohort of 176 ALS patients (mean age 66.2 years; follow-up 100%) one-year mortality rate from diagnosis was 34.1%. Multivariate analysis revealed that age over 75 years, interval between symptom onset and diagnosis below 7 months, decline of body weight before diagnosis exceeding 2 BMI units and Functional Rating Score below 31 points were independent factors predicting early death. CONCLUSIONS: Probability of early death within 12 months from diagnosis is predicted by advanced age, short interval between symptom onset and first diagnosis, rapid decline of body weight before diagnosis and advanced functional impairment. TRIAL REGISTRATION: ClinicalTrials.gov (NCT01955369, registered September 28, 2013).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12883-014-0197-9

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 17

  1. [1]Logroscino G Traynor BJ Hardiman O Chio A Couratier P Mitchell JD Swingler RJ Beghi E Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues J Neurol Neurosurg Psychiatry 2008 79 6 11 10.1136/jnnp.2006.104828 18079297 · DOI
  2. [2]Millul A Beghi E Logroscino G Micheli A Vitelli E Zardi A Survival of patients with amyotrophic lateral sclerosis in a population-based registry Neuroepidemiology 2005 25 114 119 10.1159/000086353 15956808 · DOI
  3. [3]Del Aguila MA Longstreth WT McGuire V Koepsell TD van Belle G Prognosis in amyotrophic lateral sclerosis. A population-based study Neurology 2003 60 813 819 10.1212/01.WNL.0000049472.47709.3B 12629239 · DOI
  4. [4]Chio A Logroscino G Hardiman O Swingler RJ Mitchell D Beghi E Traynor B Prognostic factors in ALS: A critical review Amyotroph Lateral Scler 2009 10 310 323 10.3109/17482960802566824 19922118 PMC3515205 · DOI · Paper page
  5. [6]Wolf J Wöhrle JC Palm F Nix WA Maschke M Safer A Becher H Grau AJ Incidence of amyotrophic lateral sclerosis in Rhineland-Palatinate, Germany Amyotroph Lateral Scler 2014 15 269 74 10.3109/21678421.2014.887733 24571628 · DOI
  6. [7]Ross MA Miller RG Berchert L Parry G Barohn RJ Armon C Bryan WW Petajan J Stromatt S Goodpasture J McGuire D Toward earlier diagnosis of amyotrophic lateral sclerosis: revised criteria Neurology 1998 50 768 772 10.1212/WNL.50.3.768 9521272 · DOI
  7. [8]The ALS CNTF treatment study (ACTS) phase I-II Study Group The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis Arch Neurol 1996 53 141 147 10.1001/archneur.1996.00550020045014 8639063 · DOI
  8. [9]Zoccolella S Beghi E Palagano G Fraddosio A Guerra V Samarelli V Lepore V Simone IL Lamberti P Serlenga L Logroscino G Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: A population-based study J Neurol Neurosurg Psychiatry 2008 79 33 37 10.1136/jnnp.2007.118018 17550991 · DOI
  9. [10]Chio A Mora G Leone M Mazzini L Cocito D Giordana MT Bottacchi E Mutani R Early symptom progression rate is related to ALS outcome. A prospective population-based study Neurology 2002 59 99 103 10.1212/WNL.59.1.99 12105314 · DOI
  10. [11]Czaplinski A Yen AA Appel SH Amyotrophic lateral sclerosis: early predictors of prolonged survival J Neurol 2006 253 1428 1436 10.1007/s00415-006-0226-8 16773270 · DOI
  11. [12]Beghi E Millul A Logroscino G Vitelli E Micheli A Outcome measures and prognostic indicators in patients with amyotrophic lateral sclerosis Amyotroph Lateral Scler 2008 9 163 167 10.1080/17482960801942695 18574760 · DOI
  12. [13]Marin B Desport JC Kajeu P Jesus P Nicolaud B Nicol M Preux PM Couratier P Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients J Neurol Neurosurg Psychiatry 2011 82 628 634 10.1136/jnnp.2010.211474 21097551 · DOI
  13. [14]Shimizu T Nagaoka U Nakayama Y Kawata A Kugimoto C Kuroiwa Y Kawai M Shimohata T Nishizawa M Mihara B Arahata H Fujii N Namba R Ito H Imai T Nobukuni K Kondo K Ogino M Nakajima T Komori T Reduction rate of body mass index predicts prognosis for survival in amyotrophic lateral sclerosis: a multicenter study in Japan Amyotroph Lateral Scler 2012 13 363 366 10.3109/17482968.2012.678366 22632442 · DOI · Paper page
  14. [15]Kaufmann P Levy G Thompson JL Delbene ML Battista V Gordon PH Rowland LP Levin B Mitsumoto H The ALSFRS-R predicts survival time in an ALS clinic population Neurology 2005 64 38 43 10.1212/01.WNL.0000148648.38313.64 15642901 · DOI
  15. [16]Magnus T Beck M Giess R Naumann M Toyka KV Disease progression in amyotrophic lateral sclerosis: predictors of survival Muscle Nerve 2002 25 709 714 10.1002/mus.10090 11994965 · DOI
  16. [17]Kimura F Fujimura C Ishida S Nakajima H Furutama D Uehara H Shinoda K Sugino M Hanafusa T Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS Neurology 2006 66 265 267 10.1212/01.wnl.0000194316.91908.8a 16434671 · DOI
  17. [19]Czaplinski A Yen AA Appel SH Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population J Neurol Neurosurg Psychiatry 2006 77 390 392 10.1136/jnnp.2005.072660 16484652 PMC2077717 · DOI

Cited by

Sorted by citations

Authors
Wolf, J., Safer, A., Wöhrle, J. C., Palm, F., Nix, W. A., Maschke, M., & Grau, A. J.
Affiliations
  • Klinikum Ludwigshafen (DE)
  • Heidelberg University (DE)
  • Katholisches Klinikum Koblenz (DE)
  • Johannes Gutenberg University Mainz (DE)
  • Krankenhaus der Barmherzigen Brüder Trier (DE)
Corresponding author
Wolf, Joachim
Venue
BMC Neurology
Published
2014-10-04
Volume
14
Issue
1
Pages
197-197
ISSN
1471-2377 (ISSN-L)
OpenAlex
W1973668000
Cited by
60
References
1
Citations by year
2026: 4 · 2025: 2 · 2024: 7 · 2023: 7 · 2022: 4 · 2021: 4 · 2020: 5 · 2019: 5 · 2018: 2 · 2017: 11 · 2016: 6 · 2015: 2 · 2014: 1
FWCI
4.35
Type
journal article
Language
en
Open access
Locations
  • BMC Neurology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Health Sciences › Medicine › Genetics › Neurogenetic and Muscular Disorders Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Amyloidosis: Diagnosis, Treatment, Outcomes
Keywords
amyotrophic lateral sclerosis, one-year mortality, prognostic factors, older adults aged 75 and over, time to diagnosis, symptom onset, weight loss, functional disability, functional rating scale, disease progression
MeSH terms
Adult, Aged, Aged, 80 and over, Amyotrophic Lateral Sclerosis, Clinical Trials as Topic, Female, Germany, Humans, Male, Middle Aged, Prospective Studies, Registries, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review